State Street

State Street’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

State Street’s Portfolio PRVL Stock Details PRVL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$5.55M	Sell
2020 Q3	$2.57M	Buy
2020 Q2	$3.65M	Buy
2020 Q1	$2.55M	Buy
2019 Q4	$1.66M	Buy
2019 Q3	$763K	Buy